1. Home
  2. ALT vs USCB Comparison

ALT vs USCB Comparison

Compare ALT & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • USCB
  • Stock Information
  • Founded
  • ALT 1997
  • USCB 2002
  • Country
  • ALT United States
  • USCB United States
  • Employees
  • ALT N/A
  • USCB N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • USCB Major Banks
  • Sector
  • ALT Health Care
  • USCB Finance
  • Exchange
  • ALT Nasdaq
  • USCB Nasdaq
  • Market Cap
  • ALT 348.6M
  • USCB 313.1M
  • IPO Year
  • ALT N/A
  • USCB 2021
  • Fundamental
  • Price
  • ALT $4.05
  • USCB $17.26
  • Analyst Decision
  • ALT Strong Buy
  • USCB Strong Buy
  • Analyst Count
  • ALT 7
  • USCB 3
  • Target Price
  • ALT $16.50
  • USCB $22.00
  • AVG Volume (30 Days)
  • ALT 2.8M
  • USCB 26.6K
  • Earning Date
  • ALT 11-06-2025
  • USCB 10-23-2025
  • Dividend Yield
  • ALT N/A
  • USCB 2.32%
  • EPS Growth
  • ALT N/A
  • USCB 50.82
  • EPS
  • ALT N/A
  • USCB 1.57
  • Revenue
  • ALT $20,000.00
  • USCB $92,331,000.00
  • Revenue This Year
  • ALT N/A
  • USCB $25.60
  • Revenue Next Year
  • ALT N/A
  • USCB $11.20
  • P/E Ratio
  • ALT N/A
  • USCB $11.00
  • Revenue Growth
  • ALT N/A
  • USCB 28.61
  • 52 Week Low
  • ALT $2.90
  • USCB $14.50
  • 52 Week High
  • ALT $11.16
  • USCB $21.86
  • Technical
  • Relative Strength Index (RSI)
  • ALT 54.55
  • USCB 51.10
  • Support Level
  • ALT $3.93
  • USCB $17.07
  • Resistance Level
  • ALT $4.25
  • USCB $17.73
  • Average True Range (ATR)
  • ALT 0.18
  • USCB 0.47
  • MACD
  • ALT 0.00
  • USCB 0.02
  • Stochastic Oscillator
  • ALT 56.99
  • USCB 65.69

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About USCB USCB Financial Holdings Inc.

USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.

Share on Social Networks: